Feb 14 (Reuters)-
Delta-Fly Pharma, Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2019 Dec 31, 2018 Mar 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Operating loss 1.22 loss 424 mln loss 1.07
Recurring loss 1.23 loss 501 mln loss 1.07
Net loss 1.23 loss 503 mln loss 1.07
EPS loss 276.70 yen loss 131.63 yen loss 244.85 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Delta-Fly Pharma, Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T